nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—CYP1A2—Carmustine—melanoma	0.178	0.417	CbGbCtD
Zolmitriptan—CYP1A2—Vemurafenib—melanoma	0.141	0.33	CbGbCtD
Zolmitriptan—CYP1A2—Dacarbazine—melanoma	0.108	0.253	CbGbCtD
Zolmitriptan—HTR1D—meninx—melanoma	0.0398	0.601	CbGeAlD
Zolmitriptan—HTR1B—blood vessel—melanoma	0.00467	0.0704	CbGeAlD
Zolmitriptan—HTR1D—blood vessel—melanoma	0.00452	0.0682	CbGeAlD
Zolmitriptan—HTR1F—head—melanoma	0.00344	0.0519	CbGeAlD
Zolmitriptan—MAOA—neck—melanoma	0.00246	0.0372	CbGeAlD
Zolmitriptan—HTR1D—eye—melanoma	0.00241	0.0363	CbGeAlD
Zolmitriptan—MAOA—retina—melanoma	0.00181	0.0274	CbGeAlD
Zolmitriptan—MAOA—mammalian vulva—melanoma	0.00145	0.0219	CbGeAlD
Zolmitriptan—Melatonin—CYP1B1—melanoma	0.00144	0.575	CrCbGaD
Zolmitriptan—HTR1B—head—melanoma	0.00141	0.0213	CbGeAlD
Zolmitriptan—HTR1D—head—melanoma	0.00137	0.0206	CbGeAlD
Zolmitriptan—HTR1A—head—melanoma	0.00114	0.0172	CbGeAlD
Zolmitriptan—MAOA—head—melanoma	0.00104	0.0157	CbGeAlD
Zolmitriptan—Sinusitis—Temozolomide—melanoma	0.000752	0.00215	CcSEcCtD
Zolmitriptan—Erythema—Bleomycin—melanoma	0.000742	0.00213	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Carmustine—melanoma	0.000741	0.00212	CcSEcCtD
Zolmitriptan—Hallucination—Carmustine—melanoma	0.000741	0.00212	CcSEcCtD
Zolmitriptan—Hypersensitivity—Vemurafenib—melanoma	0.000737	0.00211	CcSEcCtD
Zolmitriptan—Oedema peripheral—Carmustine—melanoma	0.000733	0.0021	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Carmustine—melanoma	0.000731	0.0021	CcSEcCtD
Zolmitriptan—Atrial fibrillation—Docetaxel—melanoma	0.00073	0.00209	CcSEcCtD
Zolmitriptan—MAOA—lymph node—melanoma	0.000728	0.011	CbGeAlD
Zolmitriptan—Asthenia—Vemurafenib—melanoma	0.000717	0.00206	CcSEcCtD
Zolmitriptan—Hallucination—Temozolomide—melanoma	0.000716	0.00205	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Temozolomide—melanoma	0.000716	0.00205	CcSEcCtD
Zolmitriptan—Pharyngitis—Temozolomide—melanoma	0.000714	0.00205	CcSEcCtD
Zolmitriptan—Chills—Dactinomycin—melanoma	0.000714	0.00205	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Temozolomide—melanoma	0.00071	0.00204	CcSEcCtD
Zolmitriptan—Oedema peripheral—Temozolomide—melanoma	0.000709	0.00203	CcSEcCtD
Zolmitriptan—Pruritus—Vemurafenib—melanoma	0.000707	0.00203	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Temozolomide—melanoma	0.000707	0.00203	CcSEcCtD
Zolmitriptan—Urethral disorder—Temozolomide—melanoma	0.000705	0.00202	CcSEcCtD
Zolmitriptan—Erythema—Dactinomycin—melanoma	0.000692	0.00198	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Bleomycin—melanoma	0.000689	0.00197	CcSEcCtD
Zolmitriptan—Diarrhoea—Vemurafenib—melanoma	0.000684	0.00196	CcSEcCtD
Zolmitriptan—Migraine—Docetaxel—melanoma	0.000681	0.00195	CcSEcCtD
Zolmitriptan—Tinnitus—Temozolomide—melanoma	0.000671	0.00192	CcSEcCtD
Zolmitriptan—Malaise—Bleomycin—melanoma	0.000669	0.00192	CcSEcCtD
Zolmitriptan—Cardiac disorder—Temozolomide—melanoma	0.000668	0.00191	CcSEcCtD
Zolmitriptan—Arrhythmia—Carmustine—melanoma	0.000665	0.00191	CcSEcCtD
Zolmitriptan—Leukopenia—Bleomycin—melanoma	0.000664	0.0019	CcSEcCtD
Zolmitriptan—Dizziness—Vemurafenib—melanoma	0.000661	0.0019	CcSEcCtD
Zolmitriptan—Angiopathy—Temozolomide—melanoma	0.000653	0.00187	CcSEcCtD
Zolmitriptan—Ataxia—Docetaxel—melanoma	0.00065	0.00186	CcSEcCtD
Zolmitriptan—Immune system disorder—Temozolomide—melanoma	0.00065	0.00186	CcSEcCtD
Zolmitriptan—Erythema—Carmustine—melanoma	0.000648	0.00186	CcSEcCtD
Zolmitriptan—Cough—Bleomycin—melanoma	0.000648	0.00186	CcSEcCtD
Zolmitriptan—Chills—Temozolomide—melanoma	0.000645	0.00185	CcSEcCtD
Zolmitriptan—Dehydration—Docetaxel—melanoma	0.000643	0.00184	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Dactinomycin—melanoma	0.000642	0.00184	CcSEcCtD
Zolmitriptan—Vomiting—Vemurafenib—melanoma	0.000636	0.00182	CcSEcCtD
Zolmitriptan—Chest pain—Bleomycin—melanoma	0.000632	0.00181	CcSEcCtD
Zolmitriptan—Myalgia—Bleomycin—melanoma	0.000632	0.00181	CcSEcCtD
Zolmitriptan—Orthostatic hypotension—Docetaxel—melanoma	0.000632	0.00181	CcSEcCtD
Zolmitriptan—Rash—Vemurafenib—melanoma	0.00063	0.00181	CcSEcCtD
Zolmitriptan—Dermatitis—Vemurafenib—melanoma	0.00063	0.00181	CcSEcCtD
Zolmitriptan—Back pain—Carmustine—melanoma	0.000627	0.0018	CcSEcCtD
Zolmitriptan—Headache—Vemurafenib—melanoma	0.000626	0.0018	CcSEcCtD
Zolmitriptan—Erythema—Temozolomide—melanoma	0.000626	0.00179	CcSEcCtD
Zolmitriptan—Discomfort—Bleomycin—melanoma	0.000624	0.00179	CcSEcCtD
Zolmitriptan—Malaise—Dactinomycin—melanoma	0.000624	0.00179	CcSEcCtD
Zolmitriptan—Leukopenia—Dactinomycin—melanoma	0.00062	0.00178	CcSEcCtD
Zolmitriptan—Dysgeusia—Temozolomide—melanoma	0.000613	0.00176	CcSEcCtD
Zolmitriptan—Confusional state—Bleomycin—melanoma	0.000611	0.00175	CcSEcCtD
Zolmitriptan—Tremor—Carmustine—melanoma	0.000607	0.00174	CcSEcCtD
Zolmitriptan—Oedema—Bleomycin—melanoma	0.000606	0.00174	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Bleomycin—melanoma	0.000606	0.00174	CcSEcCtD
Zolmitriptan—Back pain—Temozolomide—melanoma	0.000606	0.00174	CcSEcCtD
Zolmitriptan—Infection—Bleomycin—melanoma	0.000602	0.00173	CcSEcCtD
Zolmitriptan—Dysphagia—Docetaxel—melanoma	0.000598	0.00171	CcSEcCtD
Zolmitriptan—Agitation—Carmustine—melanoma	0.000595	0.00171	CcSEcCtD
Zolmitriptan—Nausea—Vemurafenib—melanoma	0.000594	0.0017	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Bleomycin—melanoma	0.000593	0.0017	CcSEcCtD
Zolmitriptan—Myalgia—Dactinomycin—melanoma	0.000589	0.00169	CcSEcCtD
Zolmitriptan—Bronchospasm—Docetaxel—melanoma	0.000588	0.00169	CcSEcCtD
Zolmitriptan—Sumatriptan—ABCB1—melanoma	0.000587	0.235	CrCbGaD
Zolmitriptan—Tremor—Temozolomide—melanoma	0.000587	0.00168	CcSEcCtD
Zolmitriptan—Discomfort—Dactinomycin—melanoma	0.000582	0.00167	CcSEcCtD
Zolmitriptan—Angina pectoris—Docetaxel—melanoma	0.000582	0.00167	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Temozolomide—melanoma	0.000581	0.00167	CcSEcCtD
Zolmitriptan—Leukopenia—Carmustine—melanoma	0.00058	0.00166	CcSEcCtD
Zolmitriptan—Anorexia—Bleomycin—melanoma	0.000577	0.00166	CcSEcCtD
Zolmitriptan—Agitation—Temozolomide—melanoma	0.000575	0.00165	CcSEcCtD
Zolmitriptan—Angioedema—Temozolomide—melanoma	0.000572	0.00164	CcSEcCtD
Zolmitriptan—Oedema—Dactinomycin—melanoma	0.000565	0.00162	CcSEcCtD
Zolmitriptan—Malaise—Temozolomide—melanoma	0.000565	0.00162	CcSEcCtD
Zolmitriptan—Vertigo—Temozolomide—melanoma	0.000563	0.00161	CcSEcCtD
Zolmitriptan—Convulsion—Carmustine—melanoma	0.000561	0.00161	CcSEcCtD
Zolmitriptan—Infection—Dactinomycin—melanoma	0.000561	0.00161	CcSEcCtD
Zolmitriptan—Leukopenia—Temozolomide—melanoma	0.00056	0.00161	CcSEcCtD
Zolmitriptan—Hypertension—Carmustine—melanoma	0.000559	0.0016	CcSEcCtD
Zolmitriptan—Palpitations—Temozolomide—melanoma	0.000553	0.00159	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Dactinomycin—melanoma	0.000553	0.00159	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Bleomycin—melanoma	0.000552	0.00158	CcSEcCtD
Zolmitriptan—Myalgia—Carmustine—melanoma	0.000552	0.00158	CcSEcCtD
Zolmitriptan—Chest pain—Carmustine—melanoma	0.000552	0.00158	CcSEcCtD
Zolmitriptan—Anxiety—Carmustine—melanoma	0.00055	0.00158	CcSEcCtD
Zolmitriptan—Cough—Temozolomide—melanoma	0.000546	0.00157	CcSEcCtD
Zolmitriptan—Paraesthesia—Bleomycin—melanoma	0.000544	0.00156	CcSEcCtD
Zolmitriptan—Weight increased—Docetaxel—melanoma	0.000544	0.00156	CcSEcCtD
Zolmitriptan—Convulsion—Temozolomide—melanoma	0.000543	0.00156	CcSEcCtD
Zolmitriptan—Hypertension—Temozolomide—melanoma	0.000541	0.00155	CcSEcCtD
Zolmitriptan—Dyspnoea—Bleomycin—melanoma	0.00054	0.00155	CcSEcCtD
Zolmitriptan—Anorexia—Dactinomycin—melanoma	0.000539	0.00154	CcSEcCtD
Zolmitriptan—Pneumonia—Docetaxel—melanoma	0.000536	0.00154	CcSEcCtD
Zolmitriptan—Confusional state—Carmustine—melanoma	0.000533	0.00153	CcSEcCtD
Zolmitriptan—Myalgia—Temozolomide—melanoma	0.000533	0.00153	CcSEcCtD
Zolmitriptan—Arthralgia—Temozolomide—melanoma	0.000533	0.00153	CcSEcCtD
Zolmitriptan—Anxiety—Temozolomide—melanoma	0.000531	0.00152	CcSEcCtD
Zolmitriptan—Oedema—Carmustine—melanoma	0.000529	0.00152	CcSEcCtD
Zolmitriptan—Discomfort—Temozolomide—melanoma	0.000527	0.00151	CcSEcCtD
Zolmitriptan—Decreased appetite—Bleomycin—melanoma	0.000527	0.00151	CcSEcCtD
Zolmitriptan—Infection—Carmustine—melanoma	0.000525	0.00151	CcSEcCtD
Zolmitriptan—Acute coronary syndrome—Docetaxel—melanoma	0.000525	0.00151	CcSEcCtD
Zolmitriptan—Myocardial infarction—Docetaxel—melanoma	0.000522	0.0015	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Docetaxel—melanoma	0.000522	0.0015	CcSEcCtD
Zolmitriptan—Dry mouth—Temozolomide—melanoma	0.000521	0.00149	CcSEcCtD
Zolmitriptan—Jaundice—Docetaxel—melanoma	0.000519	0.00149	CcSEcCtD
Zolmitriptan—Stomatitis—Docetaxel—melanoma	0.000519	0.00149	CcSEcCtD
Zolmitriptan—Pain—Bleomycin—melanoma	0.000518	0.00149	CcSEcCtD
Zolmitriptan—Conjunctivitis—Docetaxel—melanoma	0.000518	0.00148	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Carmustine—melanoma	0.000518	0.00148	CcSEcCtD
Zolmitriptan—Tachycardia—Carmustine—melanoma	0.000516	0.00148	CcSEcCtD
Zolmitriptan—Confusional state—Temozolomide—melanoma	0.000515	0.00148	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000515	0.00148	CcSEcCtD
Zolmitriptan—Oedema—Temozolomide—melanoma	0.000511	0.00146	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Temozolomide—melanoma	0.000511	0.00146	CcSEcCtD
Zolmitriptan—Infection—Temozolomide—melanoma	0.000508	0.00146	CcSEcCtD
Zolmitriptan—Anorexia—Carmustine—melanoma	0.000504	0.00144	CcSEcCtD
Zolmitriptan—Epistaxis—Docetaxel—melanoma	0.000503	0.00144	CcSEcCtD
Zolmitriptan—Nervous system disorder—Temozolomide—melanoma	0.000501	0.00144	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Temozolomide—melanoma	0.0005	0.00143	CcSEcCtD
Zolmitriptan—Feeling abnormal—Bleomycin—melanoma	0.000499	0.00143	CcSEcCtD
Zolmitriptan—Skin disorder—Temozolomide—melanoma	0.000496	0.00142	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Temozolomide—melanoma	0.000494	0.00142	CcSEcCtD
Zolmitriptan—Decreased appetite—Dactinomycin—melanoma	0.000491	0.00141	CcSEcCtD
Zolmitriptan—Anorexia—Temozolomide—melanoma	0.000487	0.0014	CcSEcCtD
Zolmitriptan—Pain—Dactinomycin—melanoma	0.000483	0.00138	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Carmustine—melanoma	0.000482	0.00138	CcSEcCtD
Zolmitriptan—Urticaria—Bleomycin—melanoma	0.000481	0.00138	CcSEcCtD
Zolmitriptan—Rhinitis—Docetaxel—melanoma	0.00048	0.00137	CcSEcCtD
Zolmitriptan—Body temperature increased—Bleomycin—melanoma	0.000479	0.00137	CcSEcCtD
Zolmitriptan—Insomnia—Carmustine—melanoma	0.000478	0.00137	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Docetaxel—melanoma	0.000476	0.00136	CcSEcCtD
Zolmitriptan—Eletriptan—ABCB1—melanoma	0.000475	0.19	CrCbGaD
Zolmitriptan—Paraesthesia—Carmustine—melanoma	0.000475	0.00136	CcSEcCtD
Zolmitriptan—Pharyngitis—Docetaxel—melanoma	0.000475	0.00136	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Docetaxel—melanoma	0.000472	0.00135	CcSEcCtD
Zolmitriptan—Dyspnoea—Carmustine—melanoma	0.000471	0.00135	CcSEcCtD
Zolmitriptan—Oedema peripheral—Docetaxel—melanoma	0.000471	0.00135	CcSEcCtD
Zolmitriptan—Somnolence—Carmustine—melanoma	0.00047	0.00135	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Docetaxel—melanoma	0.00047	0.00135	CcSEcCtD
Zolmitriptan—Urethral disorder—Docetaxel—melanoma	0.000469	0.00134	CcSEcCtD
Zolmitriptan—Feeling abnormal—Dactinomycin—melanoma	0.000466	0.00133	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Temozolomide—melanoma	0.000466	0.00133	CcSEcCtD
Zolmitriptan—Insomnia—Temozolomide—melanoma	0.000462	0.00132	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Dactinomycin—melanoma	0.000462	0.00132	CcSEcCtD
Zolmitriptan—Decreased appetite—Carmustine—melanoma	0.00046	0.00132	CcSEcCtD
Zolmitriptan—Paraesthesia—Temozolomide—melanoma	0.000459	0.00132	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Carmustine—melanoma	0.000457	0.00131	CcSEcCtD
Zolmitriptan—Dyspnoea—Temozolomide—melanoma	0.000456	0.00131	CcSEcCtD
Zolmitriptan—Somnolence—Temozolomide—melanoma	0.000454	0.0013	CcSEcCtD
Zolmitriptan—Pain—Carmustine—melanoma	0.000452	0.0013	CcSEcCtD
Zolmitriptan—Constipation—Carmustine—melanoma	0.000452	0.0013	CcSEcCtD
Zolmitriptan—Dyspepsia—Temozolomide—melanoma	0.00045	0.00129	CcSEcCtD
Zolmitriptan—Abdominal pain—Dactinomycin—melanoma	0.000447	0.00128	CcSEcCtD
Zolmitriptan—Body temperature increased—Dactinomycin—melanoma	0.000447	0.00128	CcSEcCtD
Zolmitriptan—Hypersensitivity—Bleomycin—melanoma	0.000446	0.00128	CcSEcCtD
Zolmitriptan—Decreased appetite—Temozolomide—melanoma	0.000444	0.00127	CcSEcCtD
Zolmitriptan—Cardiac disorder—Docetaxel—melanoma	0.000444	0.00127	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Temozolomide—melanoma	0.000441	0.00126	CcSEcCtD
Zolmitriptan—Constipation—Temozolomide—melanoma	0.000437	0.00125	CcSEcCtD
Zolmitriptan—Pain—Temozolomide—melanoma	0.000437	0.00125	CcSEcCtD
Zolmitriptan—Feeling abnormal—Carmustine—melanoma	0.000436	0.00125	CcSEcCtD
Zolmitriptan—Asthenia—Bleomycin—melanoma	0.000435	0.00125	CcSEcCtD
Zolmitriptan—Angiopathy—Docetaxel—melanoma	0.000434	0.00124	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Carmustine—melanoma	0.000432	0.00124	CcSEcCtD
Zolmitriptan—Immune system disorder—Docetaxel—melanoma	0.000432	0.00124	CcSEcCtD
Zolmitriptan—Chills—Docetaxel—melanoma	0.000429	0.00123	CcSEcCtD
Zolmitriptan—Pruritus—Bleomycin—melanoma	0.000429	0.00123	CcSEcCtD
Zolmitriptan—Arrhythmia—Docetaxel—melanoma	0.000427	0.00122	CcSEcCtD
Zolmitriptan—Feeling abnormal—Temozolomide—melanoma	0.000421	0.00121	CcSEcCtD
Zolmitriptan—Body temperature increased—Carmustine—melanoma	0.000418	0.0012	CcSEcCtD
Zolmitriptan—Abdominal pain—Carmustine—melanoma	0.000418	0.0012	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Temozolomide—melanoma	0.000418	0.0012	CcSEcCtD
Zolmitriptan—Erythema—Docetaxel—melanoma	0.000416	0.00119	CcSEcCtD
Zolmitriptan—Hypersensitivity—Dactinomycin—melanoma	0.000416	0.00119	CcSEcCtD
Zolmitriptan—Dysgeusia—Docetaxel—melanoma	0.000408	0.00117	CcSEcCtD
Zolmitriptan—Urticaria—Temozolomide—melanoma	0.000406	0.00116	CcSEcCtD
Zolmitriptan—Asthenia—Dactinomycin—melanoma	0.000405	0.00116	CcSEcCtD
Zolmitriptan—Body temperature increased—Temozolomide—melanoma	0.000404	0.00116	CcSEcCtD
Zolmitriptan—Abdominal pain—Temozolomide—melanoma	0.000404	0.00116	CcSEcCtD
Zolmitriptan—Back pain—Docetaxel—melanoma	0.000403	0.00115	CcSEcCtD
Zolmitriptan—Muscle spasms—Docetaxel—melanoma	0.0004	0.00115	CcSEcCtD
Zolmitriptan—Hypersensitivity—Carmustine—melanoma	0.00039	0.00112	CcSEcCtD
Zolmitriptan—Diarrhoea—Dactinomycin—melanoma	0.000387	0.00111	CcSEcCtD
Zolmitriptan—Vomiting—Bleomycin—melanoma	0.000385	0.0011	CcSEcCtD
Zolmitriptan—Rash—Bleomycin—melanoma	0.000382	0.00109	CcSEcCtD
Zolmitriptan—Dermatitis—Bleomycin—melanoma	0.000382	0.00109	CcSEcCtD
Zolmitriptan—Asthenia—Carmustine—melanoma	0.000379	0.00109	CcSEcCtD
Zolmitriptan—Hypersensitivity—Temozolomide—melanoma	0.000377	0.00108	CcSEcCtD
Zolmitriptan—Syncope—Docetaxel—melanoma	0.000373	0.00107	CcSEcCtD
Zolmitriptan—Leukopenia—Docetaxel—melanoma	0.000373	0.00107	CcSEcCtD
Zolmitriptan—Palpitations—Docetaxel—melanoma	0.000368	0.00105	CcSEcCtD
Zolmitriptan—Asthenia—Temozolomide—melanoma	0.000367	0.00105	CcSEcCtD
Zolmitriptan—Loss of consciousness—Docetaxel—melanoma	0.000366	0.00105	CcSEcCtD
Zolmitriptan—Cough—Docetaxel—melanoma	0.000363	0.00104	CcSEcCtD
Zolmitriptan—Diarrhoea—Carmustine—melanoma	0.000362	0.00104	CcSEcCtD
Zolmitriptan—Pruritus—Temozolomide—melanoma	0.000362	0.00104	CcSEcCtD
Zolmitriptan—Convulsion—Docetaxel—melanoma	0.000361	0.00103	CcSEcCtD
Zolmitriptan—Nausea—Bleomycin—melanoma	0.00036	0.00103	CcSEcCtD
Zolmitriptan—Hypertension—Docetaxel—melanoma	0.00036	0.00103	CcSEcCtD
Zolmitriptan—Vomiting—Dactinomycin—melanoma	0.000359	0.00103	CcSEcCtD
Zolmitriptan—Rash—Dactinomycin—melanoma	0.000356	0.00102	CcSEcCtD
Zolmitriptan—Myalgia—Docetaxel—melanoma	0.000355	0.00102	CcSEcCtD
Zolmitriptan—Arthralgia—Docetaxel—melanoma	0.000355	0.00102	CcSEcCtD
Zolmitriptan—Chest pain—Docetaxel—melanoma	0.000355	0.00102	CcSEcCtD
Zolmitriptan—Dizziness—Carmustine—melanoma	0.00035	0.001	CcSEcCtD
Zolmitriptan—Diarrhoea—Temozolomide—melanoma	0.00035	0.001	CcSEcCtD
Zolmitriptan—Dry mouth—Docetaxel—melanoma	0.000347	0.000994	CcSEcCtD
Zolmitriptan—Confusional state—Docetaxel—melanoma	0.000343	0.000982	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Docetaxel—melanoma	0.00034	0.000974	CcSEcCtD
Zolmitriptan—Oedema—Docetaxel—melanoma	0.00034	0.000974	CcSEcCtD
Zolmitriptan—Dizziness—Temozolomide—melanoma	0.000338	0.000969	CcSEcCtD
Zolmitriptan—Infection—Docetaxel—melanoma	0.000338	0.000968	CcSEcCtD
Zolmitriptan—Vomiting—Carmustine—melanoma	0.000336	0.000964	CcSEcCtD
Zolmitriptan—Nausea—Dactinomycin—melanoma	0.000336	0.000962	CcSEcCtD
Zolmitriptan—Shock—Docetaxel—melanoma	0.000334	0.000958	CcSEcCtD
Zolmitriptan—Rash—Carmustine—melanoma	0.000333	0.000956	CcSEcCtD
Zolmitriptan—Nervous system disorder—Docetaxel—melanoma	0.000333	0.000955	CcSEcCtD
Zolmitriptan—Dermatitis—Carmustine—melanoma	0.000333	0.000955	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Docetaxel—melanoma	0.000333	0.000954	CcSEcCtD
Zolmitriptan—Tachycardia—Docetaxel—melanoma	0.000332	0.000951	CcSEcCtD
Zolmitriptan—Headache—Carmustine—melanoma	0.000331	0.00095	CcSEcCtD
Zolmitriptan—Skin disorder—Docetaxel—melanoma	0.00033	0.000946	CcSEcCtD
Zolmitriptan—Vomiting—Temozolomide—melanoma	0.000325	0.000931	CcSEcCtD
Zolmitriptan—Anorexia—Docetaxel—melanoma	0.000324	0.000929	CcSEcCtD
Zolmitriptan—Rash—Temozolomide—melanoma	0.000322	0.000924	CcSEcCtD
Zolmitriptan—Dermatitis—Temozolomide—melanoma	0.000322	0.000923	CcSEcCtD
Zolmitriptan—Headache—Temozolomide—melanoma	0.00032	0.000918	CcSEcCtD
Zolmitriptan—Nausea—Carmustine—melanoma	0.000314	0.0009	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Docetaxel—melanoma	0.00031	0.000888	CcSEcCtD
Zolmitriptan—Insomnia—Docetaxel—melanoma	0.000307	0.000881	CcSEcCtD
Zolmitriptan—Paraesthesia—Docetaxel—melanoma	0.000305	0.000875	CcSEcCtD
Zolmitriptan—Nausea—Temozolomide—melanoma	0.000304	0.00087	CcSEcCtD
Zolmitriptan—Dyspnoea—Docetaxel—melanoma	0.000303	0.000868	CcSEcCtD
Zolmitriptan—Somnolence—Docetaxel—melanoma	0.000302	0.000866	CcSEcCtD
Zolmitriptan—Dyspepsia—Docetaxel—melanoma	0.000299	0.000857	CcSEcCtD
Zolmitriptan—Decreased appetite—Docetaxel—melanoma	0.000295	0.000847	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Docetaxel—melanoma	0.000293	0.000841	CcSEcCtD
Zolmitriptan—Pain—Docetaxel—melanoma	0.000291	0.000833	CcSEcCtD
Zolmitriptan—Constipation—Docetaxel—melanoma	0.000291	0.000833	CcSEcCtD
Zolmitriptan—Feeling abnormal—Docetaxel—melanoma	0.00028	0.000803	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Docetaxel—melanoma	0.000278	0.000797	CcSEcCtD
Zolmitriptan—Body temperature increased—Docetaxel—melanoma	0.000269	0.00077	CcSEcCtD
Zolmitriptan—Abdominal pain—Docetaxel—melanoma	0.000269	0.00077	CcSEcCtD
Zolmitriptan—Hypersensitivity—Docetaxel—melanoma	0.00025	0.000718	CcSEcCtD
Zolmitriptan—Asthenia—Docetaxel—melanoma	0.000244	0.000699	CcSEcCtD
Zolmitriptan—Pruritus—Docetaxel—melanoma	0.00024	0.000689	CcSEcCtD
Zolmitriptan—Diarrhoea—Docetaxel—melanoma	0.000233	0.000667	CcSEcCtD
Zolmitriptan—Dizziness—Docetaxel—melanoma	0.000225	0.000644	CcSEcCtD
Zolmitriptan—Vomiting—Docetaxel—melanoma	0.000216	0.000619	CcSEcCtD
Zolmitriptan—Rash—Docetaxel—melanoma	0.000214	0.000614	CcSEcCtD
Zolmitriptan—Dermatitis—Docetaxel—melanoma	0.000214	0.000614	CcSEcCtD
Zolmitriptan—Headache—Docetaxel—melanoma	0.000213	0.00061	CcSEcCtD
Zolmitriptan—Nausea—Docetaxel—melanoma	0.000202	0.000579	CcSEcCtD
Zolmitriptan—CYP1A2—Metabolism—GPAM—melanoma	3e-05	0.000192	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CB—melanoma	2.99e-05	0.000192	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL2—melanoma	2.97e-05	0.000191	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TERT—melanoma	2.96e-05	0.00019	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RAC1—melanoma	2.95e-05	0.000189	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL2—melanoma	2.91e-05	0.000187	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TERT—melanoma	2.9e-05	0.000186	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RAC1—melanoma	2.89e-05	0.000185	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCL8—melanoma	2.87e-05	0.000184	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—HRAS—melanoma	2.85e-05	0.000183	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HIF1A—melanoma	2.83e-05	0.000182	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CDKN1B—melanoma	2.8e-05	0.00018	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SOCS1—melanoma	2.79e-05	0.000179	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—MAP2K1—melanoma	2.79e-05	0.000179	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—S100B—melanoma	2.79e-05	0.000179	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AKT1—melanoma	2.77e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HIF1A—melanoma	2.77e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CD—melanoma	2.77e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CASP3—melanoma	2.75e-05	0.000176	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL2—melanoma	2.74e-05	0.000176	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6—melanoma	2.73e-05	0.000175	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KDR—melanoma	2.71e-05	0.000174	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCND1—melanoma	2.67e-05	0.000172	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ERBB4—melanoma	2.66e-05	0.000171	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CB—melanoma	2.66e-05	0.00017	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KDR—melanoma	2.65e-05	0.00017	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CTNNB1—melanoma	2.65e-05	0.00017	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN2B—melanoma	2.64e-05	0.000169	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CG—melanoma	2.62e-05	0.000168	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FN1—melanoma	2.61e-05	0.000167	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MMP9—melanoma	2.6e-05	0.000167	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CDKN1A—melanoma	2.59e-05	0.000166	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PTEN—melanoma	2.58e-05	0.000166	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NFKB1—melanoma	2.57e-05	0.000165	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CD86—melanoma	2.55e-05	0.000164	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCL8—melanoma	2.55e-05	0.000164	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FN1—melanoma	2.55e-05	0.000164	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOTCH1—melanoma	2.55e-05	0.000164	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PLA2G6—melanoma	2.55e-05	0.000163	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EDN1—melanoma	2.53e-05	0.000163	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARG—melanoma	2.53e-05	0.000162	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AKT1—melanoma	2.52e-05	0.000162	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CD80—melanoma	2.5e-05	0.00016	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOTCH1—melanoma	2.5e-05	0.00016	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KIT—melanoma	2.49e-05	0.00016	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CG—melanoma	2.49e-05	0.00016	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APC—melanoma	2.49e-05	0.00016	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—NRAS—melanoma	2.49e-05	0.00016	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CSF2—melanoma	2.48e-05	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGF1—melanoma	2.48e-05	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGF—melanoma	2.46e-05	0.000158	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CD80—melanoma	2.45e-05	0.000157	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CG—melanoma	2.44e-05	0.000157	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KIT—melanoma	2.44e-05	0.000157	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APC—melanoma	2.44e-05	0.000157	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—NRAS—melanoma	2.44e-05	0.000157	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—IL2—melanoma	2.44e-05	0.000157	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—E2F1—melanoma	2.42e-05	0.000155	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGF—melanoma	2.41e-05	0.000155	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CB—melanoma	2.41e-05	0.000155	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PDGFRA—melanoma	2.4e-05	0.000154	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—MAPK3—melanoma	2.39e-05	0.000153	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PRKCA—melanoma	2.37e-05	0.000152	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ITGB3—melanoma	2.37e-05	0.000152	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BRAF—melanoma	2.34e-05	0.00015	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—MAPK3—melanoma	2.34e-05	0.00015	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—melanoma	2.33e-05	0.00015	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SPP1—melanoma	2.33e-05	0.000149	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAP2K2—melanoma	2.32e-05	0.000149	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCL8—melanoma	2.32e-05	0.000149	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—STAT3—melanoma	2.31e-05	0.000148	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NRAS—melanoma	2.3e-05	0.000148	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CD—melanoma	2.3e-05	0.000148	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BRAF—melanoma	2.29e-05	0.000147	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—VCAN—melanoma	2.29e-05	0.000147	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF1—melanoma	2.28e-05	0.000146	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—MAPK1—melanoma	2.27e-05	0.000146	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—EGFR—melanoma	2.27e-05	0.000146	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALB—melanoma	2.27e-05	0.000146	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF1—melanoma	2.24e-05	0.000143	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—MAPK1—melanoma	2.22e-05	0.000143	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—EGFR—melanoma	2.22e-05	0.000143	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL2—melanoma	2.22e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TERT—melanoma	2.21e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAP2K1—melanoma	2.21e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK3—melanoma	2.21e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RAC1—melanoma	2.2e-05	0.000141	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CD—melanoma	2.19e-05	0.000141	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PIK3CA—melanoma	2.17e-05	0.000139	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.17e-05	0.000139	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAP2K1—melanoma	2.16e-05	0.000139	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CD—melanoma	2.15e-05	0.000138	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—KRAS—melanoma	2.15e-05	0.000138	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MYC—melanoma	2.15e-05	0.000138	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CA—melanoma	2.13e-05	0.000136	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HIF1A—melanoma	2.11e-05	0.000135	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—KRAS—melanoma	2.1e-05	0.000135	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK1—melanoma	2.1e-05	0.000135	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FGF2—melanoma	2.1e-05	0.000135	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EGFR—melanoma	2.1e-05	0.000135	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.09e-05	0.000134	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FGF2—melanoma	2.06e-05	0.000132	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KDR—melanoma	2.02e-05	0.00013	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CB—melanoma	2e-05	0.000129	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—melanoma	1.99e-05	0.000127	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KRAS—melanoma	1.98e-05	0.000127	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CA—melanoma	1.97e-05	0.000126	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MDM2—melanoma	1.96e-05	0.000126	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FN1—melanoma	1.94e-05	0.000125	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ERBB2—melanoma	1.94e-05	0.000124	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP17A1—melanoma	1.93e-05	0.000124	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CA—melanoma	1.93e-05	0.000124	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MDM2—melanoma	1.92e-05	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CB—melanoma	1.91e-05	0.000123	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.9e-05	0.000122	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOTCH1—melanoma	1.9e-05	0.000122	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ERBB2—melanoma	1.9e-05	0.000122	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.88e-05	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CB—melanoma	1.87e-05	0.00012	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CD80—melanoma	1.86e-05	0.00012	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KIT—melanoma	1.86e-05	0.000119	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APC—melanoma	1.86e-05	0.000119	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CG—melanoma	1.86e-05	0.000119	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—NRAS—melanoma	1.86e-05	0.000119	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGF—melanoma	1.84e-05	0.000118	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL8—melanoma	1.84e-05	0.000118	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—HRAS—melanoma	1.82e-05	0.000117	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GNA11—melanoma	1.82e-05	0.000117	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CA—melanoma	1.82e-05	0.000117	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL8—melanoma	1.8e-05	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDKN1B—melanoma	1.79e-05	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—HRAS—melanoma	1.79e-05	0.000115	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—FASN—melanoma	1.78e-05	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—MAPK3—melanoma	1.78e-05	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AKT1—melanoma	1.77e-05	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—melanoma	1.76e-05	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CASP3—melanoma	1.76e-05	0.000113	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC5A5—melanoma	1.76e-05	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN1B—melanoma	1.76e-05	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL2—melanoma	1.75e-05	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BRAF—melanoma	1.75e-05	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—melanoma	1.75e-05	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AKT1—melanoma	1.74e-05	0.000111	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTEN—melanoma	1.73e-05	0.000111	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CASP3—melanoma	1.72e-05	0.00011	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL2—melanoma	1.72e-05	0.00011	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCND1—melanoma	1.71e-05	0.00011	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—melanoma	1.71e-05	0.00011	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF1—melanoma	1.7e-05	0.000109	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GNAQ—melanoma	1.7e-05	0.000109	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CD44—melanoma	1.7e-05	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—MAPK1—melanoma	1.69e-05	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—EGFR—melanoma	1.69e-05	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CTNNB1—melanoma	1.69e-05	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HRAS—melanoma	1.69e-05	0.000108	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCND1—melanoma	1.67e-05	0.000107	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MMP9—melanoma	1.66e-05	0.000107	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.66e-05	0.000107	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CTNNB1—melanoma	1.66e-05	0.000106	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDKN1A—melanoma	1.65e-05	0.000106	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTEN—melanoma	1.65e-05	0.000106	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAP2K1—melanoma	1.65e-05	0.000106	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.65e-05	0.000106	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NFKB1—melanoma	1.64e-05	0.000105	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CD—melanoma	1.64e-05	0.000105	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP9—melanoma	1.63e-05	0.000104	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP1B1—melanoma	1.63e-05	0.000104	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN1A—melanoma	1.62e-05	0.000104	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CA—melanoma	1.62e-05	0.000104	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTEN—melanoma	1.62e-05	0.000104	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—melanoma	1.61e-05	0.000103	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AKT1—melanoma	1.61e-05	0.000103	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NFKB1—melanoma	1.61e-05	0.000103	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—KRAS—melanoma	1.6e-05	0.000103	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AKT1—melanoma	1.58e-05	0.000101	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGF2—melanoma	1.57e-05	0.0001	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—melanoma	1.49e-05	9.57e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKT1—melanoma	1.49e-05	9.54e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—STAT3—melanoma	1.48e-05	9.47e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NRAS—melanoma	1.47e-05	9.45e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CA—melanoma	1.47e-05	9.43e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MDM2—melanoma	1.46e-05	9.4e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—melanoma	1.46e-05	9.37e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—STAT3—melanoma	1.45e-05	9.27e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ERBB2—melanoma	1.44e-05	9.26e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NRAS—melanoma	1.44e-05	9.25e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.43e-05	9.2e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CB—melanoma	1.43e-05	9.14e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK3—melanoma	1.41e-05	9.05e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK3—melanoma	1.38e-05	8.86e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MYC—melanoma	1.37e-05	8.8e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL8—melanoma	1.37e-05	8.79e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—HRAS—melanoma	1.36e-05	8.73e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MYC—melanoma	1.34e-05	8.62e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK1—melanoma	1.34e-05	8.61e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGFR—melanoma	1.34e-05	8.61e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCB1—melanoma	1.34e-05	8.59e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN1B—melanoma	1.34e-05	8.58e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT1—melanoma	1.32e-05	8.49e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK1—melanoma	1.31e-05	8.43e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGFR—melanoma	1.31e-05	8.43e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CASP3—melanoma	1.31e-05	8.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL2—melanoma	1.31e-05	8.4e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—melanoma	1.3e-05	8.35e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCND1—melanoma	1.28e-05	8.18e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KRAS—melanoma	1.27e-05	8.13e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CTNNB1—melanoma	1.26e-05	8.11e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KRAS—melanoma	1.24e-05	7.96e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP9—melanoma	1.24e-05	7.95e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN1A—melanoma	1.23e-05	7.92e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PRKCA—melanoma	1.23e-05	7.9e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTEN—melanoma	1.23e-05	7.9e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NFKB1—melanoma	1.23e-05	7.86e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CA—melanoma	1.22e-05	7.84e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ERCC2—melanoma	1.22e-05	7.84e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT1—melanoma	1.2e-05	7.71e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CA—melanoma	1.16e-05	7.47e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CA—melanoma	1.14e-05	7.32e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—melanoma	1.13e-05	7.23e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—melanoma	1.11e-05	7.14e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—melanoma	1.1e-05	7.08e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—STAT3—melanoma	1.1e-05	7.07e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NRAS—melanoma	1.1e-05	7.05e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HRAS—melanoma	1.08e-05	6.91e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HRAS—melanoma	1.06e-05	6.77e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK3—melanoma	1.05e-05	6.75e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—melanoma	1.03e-05	6.62e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MYC—melanoma	1.02e-05	6.57e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.01e-05	6.49e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—melanoma	1.01e-05	6.48e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK1—melanoma	1e-05	6.42e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGFR—melanoma	1e-05	6.42e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKT1—melanoma	9.98e-06	6.41e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CG—melanoma	9.65e-06	6.19e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT1—melanoma	9.51e-06	6.1e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KRAS—melanoma	9.46e-06	6.07e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT1—melanoma	9.32e-06	5.98e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARG—melanoma	9.31e-06	5.98e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CA—melanoma	8.69e-06	5.57e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CD—melanoma	8.48e-06	5.44e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—melanoma	8.4e-06	5.39e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALB—melanoma	8.37e-06	5.37e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HRAS—melanoma	8.04e-06	5.16e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—melanoma	7.69e-06	4.94e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CB—melanoma	7.39e-06	4.74e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—melanoma	7.33e-06	4.7e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT1—melanoma	7.1e-06	4.55e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTEN—melanoma	6.39e-06	4.1e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CA—melanoma	4.51e-06	2.89e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKT1—melanoma	3.68e-06	2.36e-05	CbGpPWpGaD
